<code id='D3714356D6'></code><style id='D3714356D6'></style>
    • <acronym id='D3714356D6'></acronym>
      <center id='D3714356D6'><center id='D3714356D6'><tfoot id='D3714356D6'></tfoot></center><abbr id='D3714356D6'><dir id='D3714356D6'><tfoot id='D3714356D6'></tfoot><noframes id='D3714356D6'>

    • <optgroup id='D3714356D6'><strike id='D3714356D6'><sup id='D3714356D6'></sup></strike><code id='D3714356D6'></code></optgroup>
        1. <b id='D3714356D6'><label id='D3714356D6'><select id='D3714356D6'><dt id='D3714356D6'><span id='D3714356D6'></span></dt></select></label></b><u id='D3714356D6'></u>
          <i id='D3714356D6'><strike id='D3714356D6'><tt id='D3714356D6'><pre id='D3714356D6'></pre></tt></strike></i>

          fashion

          fashion

          author:fashion    Page View:3
          A scientist working at SQZ Biotechnologies in Watertown's Arsenal Yards. -- biotech coverage from STAT
          A scientist working at SQZ Biotechnologies in Watertown, Mass. David L Ryan/Globe Staff

          Next stop: Beacon Hill.

          Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.

          advertisement

          But lawmakers so far are noncommittal on funding the plan. The proposal — dubbed “Life Sciences 3.0″ — is part of a larger economic development bill the Healey administration is expected to file soon. Several expressed support for an industry in which Massachusetts is a leader, but also noted the spending request comes at a time of competing priorities.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more
          Medicare will require more price transparency from hospitals
          Medicare will require more price transparency from hospitals

          Medicarewillforcehospitalstobebetteraboutpublishingthepricestheychargehealthinsurersandpatients.DonP

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          The health care issue Democrats can’t solve: hospital reform

          MikeReddyforSTATWASHINGTON—Democratsunilaterallydrovemajorreformstothehealthinsuranceandthepharmaceu